SIGGF (Sigma Healthcare) 3-Year Share Buyback Ratio : -14.30% (As of Jan. 2025)

View and export this data going back to 2009. Start your Free Trial

What is Sigma Healthcare 3-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Sigma Healthcare's current 3-Year Share Buyback Ratio was -14.30%.

The historical rank and industry rank for Sigma Healthcare's 3-Year Share Buyback Ratio or its related term are showing as below:

SIGGF' s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -46.6 Med: -0.5 Max: 2.9
Current: -14.3

During the past 13 years, Sigma Healthcare's highest 3-Year Share Buyback Ratio was 2.90%. The lowest was -46.60%. And the median was -0.50%.

SIGGF's 3-Year Share Buyback Ratio is ranked worse than
88.89% of 63 companies
in the Medical Distribution industry
Industry Median: -1 vs SIGGF: -14.30

Competitive Comparison of Sigma Healthcare's 3-Year Share Buyback Ratio

For the Medical Distribution subindustry, Sigma Healthcare's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sigma Healthcare's 3-Year Share Buyback Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sigma Healthcare's 3-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Sigma Healthcare's 3-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Sigma Healthcare 3-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Sigma Healthcare (OTCPK:SIGGF) 3-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Sigma Healthcare 3-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Sigma Healthcare's 3-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Sigma Healthcare Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sigma Healthcare Ltd (OTCPK:SIGGF) » Definitions » 3-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

S5YA:Germany SIG:Australia

Address

2125 Dandenong Road, Level 6, Clayton, Melbourne, VIC, AUS, 3168

Website

https://www.sigmahealthcare.com.au

Sigma Healthcare is an Australian pharmaceutical distributor, wholesaler and pharmacy franchisor. The revenue growth prospects and returns of pharmaceutical distribution are subdued due to ongoing Pharmaceutical Benefits Scheme, or PBS, price reform, and regulated wholesale gross margins being capped at 7% for community pharmacy. As a result, Sigma and its competitors are seeking to expand into unregulated revenue streams. In addition, pharmacy ownership is restricted to pharmacists, thereby excluding direct corporate ownership and requiring exposure via a franchise business model.